These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9416548)

  • 1. Costs of specific immunotherapy.
    Negro Alvarez JM
    J Investig Allergol Clin Immunol; 1997; 7(5):362-3. PubMed ID: 9416548
    [No Abstract]   [Full Text] [Related]  

  • 2. [Allergic rhinitis and allergic asthma: SIT saves costs].
    Pohlmann BK
    Laryngorhinootologie; 2003 Jan; 82(1):68. PubMed ID: 12596723
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacoeconomic considerations for allergen immunotherapy.
    Bernstein JA
    Clin Allergy Immunol; 2004; 18():151-64. PubMed ID: 15042914
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic evaluation of sublingual immunotherapy: an analysis of literature.
    Ciprandi G; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Incorvaia C; Danneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():21-6. PubMed ID: 18924463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of specific hyposensitization in bronchial asthma and pollinosis].
    Bulakhova EK
    Vrach Delo; 1991 Feb; (2):89-91. PubMed ID: 2058136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of allergen specific immunotherapy in adult house-dust-mite-sensitive bronchial asthma: impact on disease severity and medical cost].
    Nagata M; Tabe K; Yamamoto H; Sakamoto Y; Matsuo H
    Arerugi; 1999 Dec; 48(12):1316-21. PubMed ID: 10666919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of allergy therapy].
    Horak F
    Wien Med Wochenschr; 1999; 149(14-15):444-6. PubMed ID: 10584291
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic aspects of sublingual immunotherapy.
    Incorvaia C; Ariano R; Berto P; Ciprandi G; Leo G; Boccardo R; Scurati S; Frati F
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):27-30. PubMed ID: 19944007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of asthma treatment in Spain and rationalizing the expense.
    Nieto A; Alvarez-Cuesta E; Boquete M; Mazón A; de la Torre F
    J Investig Allergol Clin Immunol; 2001; 11(3):139-48. PubMed ID: 11831444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma treatment: improving efficacy. Reducing costs.
    Muñoz-López F
    Allergol Immunopathol (Madr); 2001; 29(6):223-8. PubMed ID: 11834180
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
    Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific allergen immunotherapy for asthma. A position paper of the Thoracic Society of Australia and New Zealand and the Australasian Society of Clinical Immunology and Allergy.
    Med J Aust; 1997 Nov; 167(10):540-4. PubMed ID: 9397043
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization and cost of immunotherapy for allergic asthma and rhinitis.
    Donahue JG; Greineder DK; Connor-Lacke L; Canning CF; Platt R
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):339-47. PubMed ID: 10227332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
    Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
    Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ragweed immunotherapy in adult asthma.
    Portnoy JM; Finegold I
    N Engl J Med; 1996 Jul; 335(3):203-4; author reply 205-6. PubMed ID: 8657223
    [No Abstract]   [Full Text] [Related]  

  • 16. The health economics of allergen immunotherapy.
    Hankin CS; Cox L; Bronstone A
    Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ragweed immunotherapy in adult asthma.
    Creticos PS; Reed CE; Norman PS; Khoury J; Adkinson NF; Buncher CR; Busse WW; Bush RK; Gadde J; Li JT
    N Engl J Med; 1996 Feb; 334(8):501-6. PubMed ID: 8559203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.
    Petersen KD; Gyrd-Hansen D; Linneberg A; Dahl R; Larsen JN; Løwenstein H; Kronborg C
    Int J Technol Assess Health Care; 2010 Jan; 26(1):20-9. PubMed ID: 20059777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific immunotherapy in allergic bronchial asthma].
    Tamir R; Katz Y; Pick AI
    Harefuah; 1992 Dec; 123(12):536-40. PubMed ID: 1289204
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful immunotherapy. A partnership between consultant and general practitioner.
    Katelaris CH
    Aust Fam Physician; 1998 Aug; 27(8):687-92. PubMed ID: 9735486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.